CXCL9 and neoplasm: Circulating CXCL9 is a predictor of poor prognosis in HNSCC;51 however, in the context of CXCR3 expression in bintrafusp alfa responder tumors, it has the potential to induce antitumor immunity rather than promote tumor expansion.